Evidence map›Paper›PMID 42359276›Full record

ArticleJournal of materials science. Polymers2026

Electrospun biodegradable polycaprolactone filter media for filtering facepiece respirators.

Nathan Ewell, Sophie Fleishman, Kristen Mulherin, Gregory C Rutledge

Abstract read
In one paragraph

Article in Journal of materials science. Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nathan EwellDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 USA.ORCID 0009-0006-4718-9762
Sophie FleishmanDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 USA.
Kristen MulherinAdvanced Functional Fabrics of America, Cambridge, MA 02139 USA.
Gregory C RutledgeDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 USA.ORCID 0000-0001-8137-1732

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Filtering facepiece respirators (FFRs) protect against disease transmission and other harmful air pollutants through the collection of incident aerosolized particulates. Conventional disposable FFRs, featuring meltblown polypropylene filter layers, rely on electrostatic charges to achieve N95 performance and are not biodegradable. Electrospun filters can achieve high filtration performance without electrostatic charging due to their small fiber size and may be fabricated from environmentally degradable materials. In this work, we design filter media made of biodegradable poly(ε-caprolactone) (PCL) nanofibers electrospun from a relatively benign solvent system. These media meet N95 performance targets for filtration efficiency and inhalation and exhalation resistance under laboratory test conditions. Moreover, we demonstrate the fabrication of media having average fiber diameters between 60 nm and 300 nm, and we propose combinations of fiber diameter, solidity, and basis weight that produce filters meeting N95 targets. Our results indicate that selecting electrospun media with particularly small diameter fibers leads to better filtration performance with less material and enhanced rates of degradation. Using these insights, we fabricate prototype duckbill-style respirators featuring an electrospun PCL filter layer sandwiched between polylactic acid spunbond support layers. These prototypes meet the N95 criteria for filtration efficiency and breathing resistance under the tested conditions. Supplementary Information: The online version contains supplementary material available at 10.1007/s44493-026-00021-6.

Indexed as

AerosolBiodegradabilityElectrospinningFiltrationNanofibersRespirator

Identifiers

PMID42359276
PMCPMC13290954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.